1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
2
|
Leung WK, Wu MS, Kakugawa Y, et al:
Screening for gastric cancer in Asia: current evidence and
practice. Lancet Oncol. 9:279–287. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.
|
4
|
Bhaumik D, Scott GK, Schokrpur S, Patil
CK, Campisi J and Benz CC: Expression of microRNA-146 suppresses
NF-κB activity with reduction of metastatic potential in breast
cancer cells. Oncogene. 27:5643–5647. 2008.PubMed/NCBI
|
5
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs - the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wang X, Tang S, Le SY, et al: Aberrant
expression of oncogenic and tumor-suppressive microRNAs in cervical
cancer is required for cancer cell growth. PLoS One. 3:e25572008.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Lin SL, Chiang A, Chang D and Ying SY:
Loss of mir-146a function in hormone-refractory prostate cancer.
RNA. 14:417–424. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Jazdzewski K, Murray EL, Franssila K,
Jarzab B, Schoenberg DR and de la Chapelle A: Common SNP in
pre-miR-146a decreases mature miR expression and predisposes to
papillary thyroid carcinoma. Proc Natl Acad Sci USA. 105:7269–7274.
2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Hurst DR, Edmonds MD, Scott GK, Benz CC,
Vaidya KS and Welch DR: Breast cancer metastasis suppressor 1
up-regulates miR-146, which suppresses breast cancer metastasis.
Cancer Res. 69:1279–1283. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Mei J, Bachoo R and Zhang CL:
MicroRNA-146a inhibits glioma development by targeting Notch1. Mol
Cell Biol. 31:3584–3592. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Paik JH, Jang JY, Jeon YK, et al:
MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and
functions as a tumor suppressor having strong prognostic
implications in NK/T cell lymphoma. Clin Cancer Res. 17:4761–4771.
2011.PubMed/NCBI
|
12
|
Li Y, Vandenboom TG 2nd, Wang Z, et al:
miR-146a suppresses invasion of pancreatic cancer cells. Cancer
Res. 70:1486–1495. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Pacifico F, Crescenzi E, Mellone S, et al:
Nuclear factor-κB contributes to anaplastic thyroid carcinomas
through up-regulation of miR-146a. J Clin Endocrinol Metab.
95:1421–1430. 2010.
|
14
|
Hou Z, Xie L, Yu L, Qian X and Liu B:
MicroRNA-146a is down-regulated in gastric cancer and regulates
cell proliferation and apoptosis. Med Oncol. 29:886–892. 2012.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Kogo R, Mimori K, Tanaka F, Komune S and
Mori M: Clinical significance of miR-146a in gastric cancer cases.
Clin Cancer Res. 17:4277–4284. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Tchernitsa O, Kasajima A, Schafer R, et
al: Systematic evaluation of the miRNA-ome and its downstream
effects on mRNA expression identifies gastric cancer progression. J
Pathol. 222:310–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: a convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Raveh S, Gavert N and Ben-Ze’ev A: L1 cell
adhesion molecule (L1CAM) in invasive tumors. Cancer Lett.
282:137–145. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kodera Y, Nakanishi H, Ito S, et al:
Expression of L1 cell adhesion molecule is a significant prognostic
factor in pT3-stage gastric cancer. Anticancer Res. 29:4033–4039.
2009.PubMed/NCBI
|
20
|
Xiao B, Zhu ED, Li N, et al: Increased
miR-146a in gastric cancer directly targets SMAD4 and is involved
in modulating cell proliferation and apoptosis. Oncol Rep.
27:559–566. 2012.PubMed/NCBI
|
21
|
Rathjen FG and Schachner M:
Immunocytological and biochemical characterization of a new
neuronal cell surface component (L1 antigen) which is involved in
cell adhesion. EMBO J. 3:1–10. 1984.PubMed/NCBI
|
22
|
Gavert N, Conacci-Sorrell M, Gast D, et
al: L1, a novel target of beta-catenin signaling, transforms cells
and is expressed at the invasive front of colon cancers. J Cell
Biol. 168:633–642. 2005. View Article : Google Scholar : PubMed/NCBI
|